Fiche du document
2011
- doi: 10.1093/infdis/jir553
- issn: 0022-1899
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1093/infdis/jir553
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/21921209
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1537-6613
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_B919DFAC5DBD7
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Mononuclear phagocytes HistiocytesCiter ce document
M. Mombelli et al., « Histone deacetylase inhibitors impair antibacterial defenses of macrophages. », Serveur académique Lausannois, ID : 10.1093/infdis/jir553
Métriques
Partage / Export
Résumé
Histone deacetylases (HDACs) control gene expression by deacetylating histones and nonhistone proteins. HDAC inhibitors (HDACi) are powerful anticancer drugs that exert anti-inflammatory and immunomodulatory activities. We recently reported a proof-of-concept study demonstrating that HDACi increase susceptibility to bacterial infections in vivo. Yet, still little is known about the effects of HDACi on antimicrobial innate immune defenses. Here we show that HDACi belonging to different chemical classes inhibit at multiple levels the response of macrophages to bacterial infection. HDACi reduce the phagocytosis and the killing of Escherichia coli and Staphylococcus aureus by macrophages. In line with these findings, HDACi decrease the expression of phagocytic receptors and inhibit bacteria-induced production of reactive oxygen and nitrogen species by macrophages. Consistently, HDACi impair the expression of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunits and inducible nitric oxide synthase. These data indicate that HDACi have a strong impact on critical antimicrobial defense mechanisms in macrophages.